John B. Moriarty, EVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 10,010 shares at $199.05 ($2.0M) on 2015-08-05, disclosed to the SEC on 2015-08-05.
Open-market sale of $2.0M ALXN by EVP & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $198.12 | 6,574 | $1.3M | 65.6% |
| 2 | $199.05 | 3,436 | $684K | 34.4% |
| Total | $198.44 avg | 10,010 | $2.0M | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |